These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24831558)

  • 61. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
    Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission.
    Calafat M; Lobatón T; Hernández-Gallego A; Mañosa M; Torres P; Cañete F; Cabré E; Ojanguren I; Domènech E
    Dig Liver Dis; 2017 Dec; 49(12):1327-1331. PubMed ID: 28958412
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
    Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prediction of clinical and endoscopic responses to anti-tumor necrosis factor-α antibodies in ulcerative colitis.
    Morita Y; Bamba S; Takahashi K; Imaeda H; Nishida A; Inatomi O; Sasaki M; Tsujikawa T; Sugimoto M; Andoh A
    Scand J Gastroenterol; 2016 Aug; 51(8):934-41. PubMed ID: 26888161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Review article: defining remission in ulcerative colitis.
    Travis SP; Higgins PD; Orchard T; Van Der Woude CJ; Panaccione R; Bitton A; O'Morain C; Panés J; Sturm A; Reinisch W; Kamm MA; D'Haens G
    Aliment Pharmacol Ther; 2011 Jul; 34(2):113-24. PubMed ID: 21615435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Theede K; Holck S; Ibsen P; Kallemose T; Nordgaard-Lassen I; Nielsen AM
    Inflamm Bowel Dis; 2016 May; 22(5):1042-8. PubMed ID: 26919460
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
    Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
    Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.
    Okuyama Y; Andoh A; Nishishita M; Fukunaga K; Kamikozuru K; Yokoyama Y; Ueno Y; Tanaka S; Kuge H; Yoshikawa S; Sugahara A; Anami E; Munetomo Y; Watanabe C; Fujiyama Y; Matsumoto T
    Scand J Gastroenterol; 2013 Apr; 48(4):412-8. PubMed ID: 23356660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis.
    Higgins PD; Leung J; Schwartz M; Mapili J; Wren PA; Zimmermann EM
    Aliment Pharmacol Ther; 2007 Feb; 25(3):333-42. PubMed ID: 17269991
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bowel ultrasound and mucosal healing in ulcerative colitis.
    Parente F; Molteni M; Marino B; Colli A; Ardizzone S; Greco S; Sampietro G; Gallus S
    Dig Dis; 2009; 27(3):285-90. PubMed ID: 19786753
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission.
    Feagins LA; Melton SD; Iqbal R; Dunbar KB; Spechler SJ
    Inflamm Bowel Dis; 2013 Jun; 19(7):1477-82. PubMed ID: 23702713
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
    Walsh A; Palmer R; Travis S
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
    Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD007571. PubMed ID: 25105240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
    Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
    Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A prospective study on second-generation colon capsule endoscopy to detect mucosal lesions and disease activity in ulcerative colitis (with video).
    Shi HY; Chan FKL; Higashimori A; Kyaw M; Ching JYL; Chan HCH; Chan JCH; Chan AWH; Lam KLY; Tang RSY; Wu JCY; Sung JJY; Ng SC
    Gastrointest Endosc; 2017 Dec; 86(6):1139-1146.e6. PubMed ID: 28713062
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis.
    Ma C; MacDonald JK; Nguyen TM; Chang J; Vande Casteele N; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2022 Jan; 55(2):178-190. PubMed ID: 34821404
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis.
    Maunder RG; Greenberg GR
    Inflamm Bowel Dis; 2004 Sep; 10(5):632-6. PubMed ID: 15472526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.